Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 19/20 | 0.68 |
| ▸ | ERBB2 | P04626 | 6/20 | 0.66 |
| ▸ | KDR | P35968 | 3/20 | 0.66 |
| ▸ | BRAF | P15056 | 2/20 | 0.66 |
| ▸ | CIT | O14578 | 1/20 | 0.66 |
| ▸ | GAK | O14976 | 1/20 | 0.66 |
| ▸ | EPHB6 | O15197 | 1/20 | 0.66 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.66 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.66 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.66 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.66 |
| ▸ | RPS6KA4 | O75676 | 1/20 | 0.66 |
| ▸ | STK17B | O94768 | 1/20 | 0.66 |
| ▸ | STK10 | O94804 | 1/20 | 0.66 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.66 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.66 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.66 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.66 |
| ▸ | ABL1 | P00519 | 1/20 | 0.66 |
| ▸ | LCK | P06239 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17557976 | 1.00 | EGFR (0.68) | EGFRERBB2KDRBRAFCIT | |
| SCHEMBL17557994 | 1.00 | EGFR (0.68) | EGFRERBB2KDRBRAFCIT | |
| SCHEMBL17557968 | 1.00 | EGFR (0.68) | EGFRERBB2KDRBRAFCIT | |
| SCHEMBL17558001 | 1.00 | EGFR (0.68) | EGFRERBB2KDRBRAFCIT | |
| SCHEMBL17558004 | 1.00 | EGFR (0.68) | EGFRERBB2KDRBRAFCIT | |
| SCHEMBL17558009 | 1.00 | EGFR (0.68) | EGFRERBB2KDRBRAFCIT | |
| SCHEMBL17558018 | 1.00 | EGFR (0.68) | EGFRERBB2KDRBRAFCIT | |
| SCHEMBL17558010 | 1.00 | EGFR (0.68) | EGFRERBB2KDRBRAFCIT | |
| SCHEMBL17557981 | 1.00 | EGFR (0.68) | EGFRERBB2KDRBRAFCIT | |
| SCHEMBL17558011 | 1.00 | EGFR (0.68) | EGFRERBB2KDRBRAFCIT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9512086-B2 | Compound for promoting apoptosis of cancer cells and a pharmaceutical composition containing the same and uses thereof | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2016-12-06 | — | — | US | disclosed |
| US-20160068495-A1 | COMPOUND FOR PROMOTING APOPTOSIS OF CANCER CELLS AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND USES THEREOF | NATIONAL CHIAO TUNG UNIVERSITY (TW) | 2016-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160068495-A1 | COMPOUND FOR PROMOTING APOPTOSIS OF CANCER CELLS AND A PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND USES THEREOF | BAX, BCL2, CASP3 | EGFR 240/4885ERBB2 2351/4885KDR 2544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.